These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 25541715)
1. CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin. Fallahi M; Amelio AL; Cleveland JL; Rounbehler RJ PLoS One; 2014; 9(12):e115517. PubMed ID: 25541715 [TBL] [Abstract][Full Text] [Related]
2. Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function. Berglund AE; Scott KE; Li W; Yang C; Fernandez MR; Schaub FX; Cleveland JL; Rounbehler RJ Oncotarget; 2016 Dec; 7(50):83462-83475. PubMed ID: 27825143 [TBL] [Abstract][Full Text] [Related]
3. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. Goddio MV; Gattelli A; Slomiansky V; Lacunza E; Gingerich T; Tocci JM; Facchinetti MM; Curino AC; LaMarre J; Abba MC; Kordon EC Breast Cancer Res Treat; 2012 Oct; 135(3):749-58. PubMed ID: 22968621 [TBL] [Abstract][Full Text] [Related]
4. Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cells. Pandiri I; Chen Y; Joe Y; Kim HJ; Park J; Chung HT; Park JW Breast Cancer Res Treat; 2016 Feb; 156(1):57-64. PubMed ID: 26956973 [TBL] [Abstract][Full Text] [Related]
5. Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway. Xu L; Ning H; Gu L; Wang Q; Lu W; Peng H; Cui W; Ying B; Ross CR; Wilson GM; Wei L; Wold WS; Liu J Oncotarget; 2015 Dec; 6(39):41679-91. PubMed ID: 26497679 [TBL] [Abstract][Full Text] [Related]
6. Tristetraprolin regulates expression of VEGF and tumorigenesis in human colon cancer. Lee HH; Son YJ; Lee WH; Park YW; Chae SW; Cho WJ; Kim YM; Choi HJ; Choi DH; Jung SW; Min YJ; Park SE; Lee BJ; Cha HJ; Park JW Int J Cancer; 2010 Apr; 126(8):1817-1827. PubMed ID: 19697322 [TBL] [Abstract][Full Text] [Related]
7. Roles of Tristetraprolin in Tumorigenesis. Park JM; Lee TH; Kang TH Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380668 [TBL] [Abstract][Full Text] [Related]
8. Tumor suppressing effects of tristetraprolin and its small double-stranded RNAs in bladder cancer. Jiang W; Zhu D; Wang C; Zhu Y Cancer Med; 2021 Jan; 10(1):269-285. PubMed ID: 33259133 [TBL] [Abstract][Full Text] [Related]
9. The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes. Al-Souhibani N; Al-Ahmadi W; Hesketh JE; Blackshear PJ; Khabar KS Oncogene; 2010 Jul; 29(29):4205-15. PubMed ID: 20498646 [TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells. Lee JY; Kim HJ; Yoon NA; Lee WH; Min YJ; Ko BK; Lee BJ; Lee A; Cha HJ; Cho WJ; Park JW Nucleic Acids Res; 2013 Jun; 41(11):5614-25. PubMed ID: 23595149 [TBL] [Abstract][Full Text] [Related]
11. The RNA binding protein tristetraprolin down-regulates autophagy in lung adenocarcinoma cells. Dong F; Li C; Wang P; Deng X; Luo Q; Tang X; Xu L Exp Cell Res; 2018 Jun; 367(1):89-96. PubMed ID: 29577897 [TBL] [Abstract][Full Text] [Related]
12. Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages. Milke L; Schulz K; Weigert A; Sha W; Schmid T; Brüne B Carcinogenesis; 2013 Apr; 34(4):850-7. PubMed ID: 23241166 [TBL] [Abstract][Full Text] [Related]
13. PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis. Ren C; Yang T; Qiao P; Wang L; Han X; Lv S; Sun Y; Liu Z; Du Y; Yu Z Mol Oncol; 2018 May; 12(5):690-704. PubMed ID: 29570932 [TBL] [Abstract][Full Text] [Related]
14. Tristetraprolin specifically regulates the expression and alternative splicing of immune response genes in HeLa cells. Tu Y; Wu X; Yu F; Dang J; Wang J; Wei Y; Cai Z; Zhou Z; Liao W; Li L; Zhang Y BMC Immunol; 2019 May; 20(1):13. PubMed ID: 31046669 [TBL] [Abstract][Full Text] [Related]
15. The role of RNA-binding protein tristetraprolin in cancer and immunity. Guo J; Qu H; Chen Y; Xia J Med Oncol; 2017 Nov; 34(12):196. PubMed ID: 29124478 [TBL] [Abstract][Full Text] [Related]
16. A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. Griseri P; Bourcier C; Hieblot C; Essafi-Benkhadir K; Chamorey E; Touriol C; Pagès G Hum Mol Genet; 2011 Dec; 20(23):4556-68. PubMed ID: 21875902 [TBL] [Abstract][Full Text] [Related]
17. Identification of an AP1-ZFP36 Regulatory Network Associated with Breast Cancer Prognosis. Canzoneri R; Naipauer J; Stedile M; Rodriguez Peña A; Lacunza E; Gandini NA; Curino AC; Facchinetti MM; Coso OA; Kordon E; Abba MC J Mammary Gland Biol Neoplasia; 2020 Jun; 25(2):163-172. PubMed ID: 32248342 [TBL] [Abstract][Full Text] [Related]
18. Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP). Tran DDH; Koch A; Allister A; Saran S; Ewald F; Koch M; Nashan B; Tamura T Cell Signal; 2016 Dec; 28(12):1872-1880. PubMed ID: 27619201 [TBL] [Abstract][Full Text] [Related]
19. Systematic Analysis of AU-Rich Element Expression in Cancer Reveals Common Functional Clusters Regulated by Key RNA-Binding Proteins. Hitti E; Bakheet T; Al-Souhibani N; Moghrabi W; Al-Yahya S; Al-Ghamdi M; Al-Saif M; Shoukri MM; Lánczky A; Grépin R; Győrffy B; Pagès G; Khabar KS Cancer Res; 2016 Jul; 76(14):4068-80. PubMed ID: 27197193 [TBL] [Abstract][Full Text] [Related]
20. Tristetraprolin activation by resveratrol inhibits the proliferation and metastasis of colorectal cancer cells. Lee SR; Jin H; Kim WT; Kim WJ; Kim SZ; Leem SH; Kim SM Int J Oncol; 2018 Sep; 53(3):1269-1278. PubMed ID: 29956753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]